Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 436 entries
View as:

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05772377 Org: User:
Start: 07/01/23 End: 06/01/25 Due: 06/01/26

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

Phase: N/A Priority: Normal
NCT ID: NCT05950997 Org: User:
Start: 04/16/24 End: 09/30/26 Due: 09/30/27

A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT05896800 Org: User:
Start: 06/01/23 End: 06/30/26 Due: 06/30/27

Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)

Phase: N/A Priority: Normal
NCT ID: NCT03506750 Org: User:
Start: 06/03/17 End: 12/31/18 Due: 12/31/19

Research of Automated Maculopathy Screening Based on AI Techniques Using OCT Images

Phase: N/A Priority: Normal
NCT ID: NCT03476291 Org: User:
Start: 06/30/17 End: 12/31/20 Due: 12/31/21

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Phase: N/A Priority: Normal
NCT ID: NCT06979921 Org: User:
Start: 07/10/21 End: 06/01/25 Due: 06/01/26

Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04805736 Org: User:
Start: 03/25/21 End: 04/30/23 Due: 04/30/24

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

Phase: N/A Priority: Normal
NCT ID: NCT05967949 Org: User:
Start: 04/01/23 End: 04/01/28 Due: 04/01/29

Classic and Modified Rapid Sequence Induction for Prevention of Gastric Content Regurgitation

Phase: N/A Priority: Normal
NCT ID: NCT04312425 Org: User:
Start: 03/05/20 End: 03/15/20 Due: 03/15/21

Effect of Vericiguat on Endpoint Events in Acute Coronary Syndrome( ACS）Patients With Ejection Fraction <45%

Phase: N/A Priority: Normal
NCT ID: NCT06321094 Org: User:
Start: 10/01/23 End: 12/01/25 Due: 12/01/26

A Study on the Collection of Peripheral Blood Mononuclear Cells From Healthy Volunteers for the Development of Allogeneic Cellular Immunotherapy Products

Phase: N/A Priority: Normal
NCT ID: NCT04027855 Org: User:
Start: 09/26/19 End: 12/09/21 Due: 12/09/22

Pharmacokinetic Study of Continuous Infusion of Remazolam in Mechanically Ventilated Patients in ICU

Phase: N/A Priority: Normal
NCT ID: NCT05480787 Org: User:
Start: 02/01/22 End: 09/01/22 Due: 09/01/23

Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06409338 Org: User:
Start: 05/11/24 End: 09/30/24 Due: 09/30/25

On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06503211 Org: User:
Start: 07/31/24 End: 12/31/25 Due: 12/31/26

Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06669130 Org: User:
Start: 12/01/24 End: 10/01/27 Due: 10/01/28

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05049096 Org: User:
Start: 11/01/21 End: 11/20/23 Due: 11/20/24

PTCCO2 Monitoring During Retroperitoneoscopic Urologic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03226041 Org: User:
Start: 07/20/17 End: 06/30/20 Due: 06/30/21

RC-48 Combined With GLS-010 in HER2-overexpressed Patients With Previously Treated Unresectable Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05540483 Org: User:
Start: 08/01/22 End: 08/01/25 Due: 08/01/26

Effect of Perioperative Ultrasound-guided Remote Ischemic Conditioning on Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT05044806 Org: User:
Start: 09/01/21 End: 12/31/22 Due: 12/31/23

The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05931328 Org: User:
Start: 10/15/22 End: 10/31/26 Due: 10/31/27

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05896813 Org: User:
Start: 03/01/23 End: 01/01/25 Due: 01/01/26

Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04624711 Org: User:
Start: 03/01/21 End: 12/31/22 Due: 12/31/23

Improved Phototherapy in Patients With Vitiligo

Phase: N/A Priority: Normal
NCT ID: NCT05836441 Org: User:
Start: 01/01/22 End: 12/30/23 Due: 12/30/24

The Comparison Between the PVAM and CPVI for the Patients of PAF

Phase: N/A Priority: Normal
NCT ID: NCT03026413 Org: User:
Start: 03/31/15 End: 09/30/16 Due: 09/30/17

Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE

Phase: N/A Priority: Normal
NCT ID: NCT06607276 Org: User:
Start: 09/20/24 End: 09/20/27 Due: 09/20/28